Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy

Raúl Méndez-Giráldez; Azam Yazdani; Hanna K. Sanoff; Reza Hadi; Esmat Samiei; Alan P. Venook; Mark J. Ratain; Naim U. Rashid; Benjamin G. Vincent; Xueping Qu; Yujia Wen; Michael R. Kosorok; W. Fraser Symmans; John Paul Shen; Michael S. Lee; Scott Kopetz; Andrew B. Nixon; Monica M. Bertagnolli; Charles M. Perou; Federico Innocenti; Akram Yazdani; Heinz‐Josef Lenz; Gianluigi Pillonetto

doi:10.17615/rbz3-7m15

Related Publications

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)

Jonathan R. Dry , Sandra Pavey , Christine A. Pratilas +26 more

Abstract Selumetinib (AZD6244, ARRY-142886) is a selective, non–ATP-competitive inhibitor of mitogen-activated protein/extracellular signal–regulated kinase kinase (MEK)-1/2. Th...

2010 Cancer Research 259 citations

An Integrated Genomic-Based Approach to Individualized Treatment of Patients With Advanced-Stage Ovarian Cancer

Holly K. Dressman , Andrew Berchuck , Gina Chan +14 more

Purpose The purpose of this study was to develop an integrated genomic-based approach to personalized treatment of patients with advanced-stage ovarian cancer. We have used gene...

2007 Journal of Clinical Oncology 280 citations

Genomic correlates of clinical outcome in advanced prostate cancer

Wassim Abida , Joanna Cyrta , Glenn Heller +40 more

Heterogeneity in the genomic landscape of metastatic prostate cancer has become apparent through several comprehensive profiling efforts, but little is known about the impact of...

2019 Proceedings of the National Academy o... 1301 citations

Personalized Cancer Therapy With Selective Kinase Inhibitors: An Emerging Paradigm in Medical Oncology

Ultan McDermott , Jeff Settleman

Selective kinase inhibitors have emerged as an important class of anticancer agents, with demonstrated clinical efficacy and generally favorable toxicity profiles in several com...

2009 Journal of Clinical Oncology 127 citations

GeneSigDB—a curated database of gene expression signatures

Aedín C. Culhane , Thomas Schwarzl , Răzvan Sultana +8 more

The primary objective of most gene expression studies is the identification of one or more gene signatures; lists of genes whose transcriptional levels are uniquely associated w...

2009 Nucleic Acids Research 99 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Raúl Méndez-Giráldez, 
                                
                                    Azam Yazdani, 
                                
                                    Hanna K. Sanoff
                                
                                et al.
                            
                            (2025). 
                            Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy. 
                            UNC Libraries
                            
                            .
                            https://doi.org/10.17615/rbz3-7m15

Identifiers

DOI: 10.17615/rbz3-7m15